United States Acid Sphingomyelinase Deficiency Drug Market Report 2018

January 2018 | 102 pages | ID: UFD02FD246BEN
QYResearch

Abstracts

In this report, the United States Acid Sphingomyelinase Deficiency Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Acid Sphingomyelinase Deficiency Drug in these regions, from 2013 to 2025 (forecast).

United States Acid Sphingomyelinase Deficiency Drug market competition by top manufacturers/players, with Acid Sphingomyelinase Deficiency Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Genzyme Corporation
• La Jolla Pharmaceutical Company
• Merck & Co., Inc.
• Okklo Life Sciences BV
• Orphazyme ApS

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• LJPC-0712
• ML-SA1
• OKL-1014
• Olipudase Alfa
• OR-0005
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Acid Sphingomyelinase Deficiency Drug Market Report 2018

1 ACID SPHINGOMYELINASE DEFICIENCY DRUG OVERVIEW

1.1 Product Overview and Scope of Acid Sphingomyelinase Deficiency Drug
1.2 Classification of Acid Sphingomyelinase Deficiency Drug by Product Category
  1.2.1 United States Acid Sphingomyelinase Deficiency Drug Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Acid Sphingomyelinase Deficiency Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 LJPC-0712
  1.2.4 ML-SA1
  1.2.5 OKL-1014
  1.2.6 Olipudase Alfa
  1.2.7 OR-0005
  1.2.8 Others
1.3 United States Acid Sphingomyelinase Deficiency Drug Market by Application/End Users
  1.3.1 United States Acid Sphingomyelinase Deficiency Drug Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Acid Sphingomyelinase Deficiency Drug Market by Region
  1.4.1 United States Acid Sphingomyelinase Deficiency Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
  1.4.3 Southwest Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
  1.4.5 New England Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
  1.4.6 The South Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
  1.4.7 The Midwest Acid Sphingomyelinase Deficiency Drug Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Acid Sphingomyelinase Deficiency Drug (2013-2025)
  1.5.1 United States Acid Sphingomyelinase Deficiency Drug Sales and Growth Rate (2013-2025)
  1.5.2 United States Acid Sphingomyelinase Deficiency Drug Revenue and Growth Rate (2013-2025)

2 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Acid Sphingomyelinase Deficiency Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Acid Sphingomyelinase Deficiency Drug Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Acid Sphingomyelinase Deficiency Drug Average Price by Players/Suppliers (2013-2018)
2.4 United States Acid Sphingomyelinase Deficiency Drug Market Competitive Situation and Trends
  2.4.1 United States Acid Sphingomyelinase Deficiency Drug Market Concentration Rate
  2.4.2 United States Acid Sphingomyelinase Deficiency Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Acid Sphingomyelinase Deficiency Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Acid Sphingomyelinase Deficiency Drug Sales and Market Share by Region (2013-2018)
3.2 United States Acid Sphingomyelinase Deficiency Drug Revenue and Market Share by Region (2013-2018)
3.3 United States Acid Sphingomyelinase Deficiency Drug Price by Region (2013-2018)

4 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Acid Sphingomyelinase Deficiency Drug Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Acid Sphingomyelinase Deficiency Drug Revenue and Market Share by Type (2013-2018)
4.3 United States Acid Sphingomyelinase Deficiency Drug Price by Type (2013-2018)
4.4 United States Acid Sphingomyelinase Deficiency Drug Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Acid Sphingomyelinase Deficiency Drug Sales and Market Share by Application (2013-2018)
5.2 United States Acid Sphingomyelinase Deficiency Drug Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Genzyme Corporation
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Acid Sphingomyelinase Deficiency Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 La Jolla Pharmaceutical Company
  6.2.2 Acid Sphingomyelinase Deficiency Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
  6.3.2 Acid Sphingomyelinase Deficiency Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Okklo Life Sciences BV
  6.4.2 Acid Sphingomyelinase Deficiency Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Orphazyme ApS
  6.5.2 Acid Sphingomyelinase Deficiency Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview

7 ACID SPHINGOMYELINASE DEFICIENCY DRUG MANUFACTURING COST ANALYSIS

7.1 Acid Sphingomyelinase Deficiency Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Acid Sphingomyelinase Deficiency Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Acid Sphingomyelinase Deficiency Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACID SPHINGOMYELINASE DEFICIENCY DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Acid Sphingomyelinase Deficiency Drug Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Acid Sphingomyelinase Deficiency Drug Sales Volume Forecast by Type (2018-2025)
11.3 United States Acid Sphingomyelinase Deficiency Drug Sales Volume Forecast by Application (2018-2025)
11.4 United States Acid Sphingomyelinase Deficiency Drug Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Acid Sphingomyelinase Deficiency Drug
Figure United States Acid Sphingomyelinase Deficiency Drug Market Size (K Pcs) by Type (2013-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure LJPC-0712 Product Picture
Figure ML-SA1 Product Picture
Figure OKL-1014 Product Picture
Figure Olipudase Alfa Product Picture
Figure OR-0005 Product Picture
Figure Others Product Picture
Figure United States Acid Sphingomyelinase Deficiency Drug Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Acid Sphingomyelinase Deficiency Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) by Region (2013-2025)
Figure The West Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Acid Sphingomyelinase Deficiency Drug Sales Share by Players/Suppliers
Figure 2017 United States Acid Sphingomyelinase Deficiency Drug Sales Share by Players/Suppliers
Figure United States Acid Sphingomyelinase Deficiency Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Acid Sphingomyelinase Deficiency Drug Revenue Share by Players/Suppliers
Figure 2017 United States Acid Sphingomyelinase Deficiency Drug Revenue Share by Players/Suppliers
Table United States Market Acid Sphingomyelinase Deficiency Drug Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Acid Sphingomyelinase Deficiency Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Acid Sphingomyelinase Deficiency Drug Market Share of Top 3 Players/Suppliers
Figure United States Acid Sphingomyelinase Deficiency Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Acid Sphingomyelinase Deficiency Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Acid Sphingomyelinase Deficiency Drug Product Category
Table United States Acid Sphingomyelinase Deficiency Drug Sales (K Pcs) by Region (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Share by Region (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Share by Region (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Market Share by Region in 2017
Table United States Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Revenue Share by Region (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Region (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Region in 2017
Table United States Acid Sphingomyelinase Deficiency Drug Price (USD/Pcs) by Region (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales (K Pcs) by Type (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Share by Type (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Share by Type (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Market Share by Type in 2017
Table United States Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Acid Sphingomyelinase Deficiency Drug by Type (2013-2018)
Figure Revenue Market Share of Acid Sphingomyelinase Deficiency Drug by Type in 2017
Table United States Acid Sphingomyelinase Deficiency Drug Price (USD/Pcs) by Types (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Growth Rate by Type (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales (K Pcs) by Application (2013-2018)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Market Share by Application (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Market Share by Application (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Market Share by Application in 2017
Table United States Acid Sphingomyelinase Deficiency Drug Sales Growth Rate by Application (2013-2018)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Growth Rate by Application (2013-2018)
Table Genzyme Corporation Basic Information List
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Sales Growth Rate (2013-2018)
Figure Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Sales Market Share in United States (2013-2018)
Figure Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Revenue Market Share in United States (2013-2018)
Table La Jolla Pharmaceutical Company Basic Information List
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Sales Growth Rate (2013-2018)
Figure La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Sales Market Share in United States (2013-2018)
Figure La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Revenue Market Share in United States (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Revenue Market Share in United States (2013-2018)
Table Okklo Life Sciences BV Basic Information List
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Sales Growth Rate (2013-2018)
Figure Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Sales Market Share in United States (2013-2018)
Figure Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Revenue Market Share in United States (2013-2018)
Table Orphazyme ApS Basic Information List
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Sales Growth Rate (2013-2018)
Figure Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Sales Market Share in United States (2013-2018)
Figure Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Acid Sphingomyelinase Deficiency Drug
Figure Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug
Figure Acid Sphingomyelinase Deficiency Drug Industrial Chain Analysis
Table Raw Materials Sources of Acid Sphingomyelinase Deficiency Drug Major Players/Suppliers in 2017
Table Major Buyers of Acid Sphingomyelinase Deficiency Drug
Table Distributors/Traders List
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Acid Sphingomyelinase Deficiency Drug Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Acid Sphingomyelinase Deficiency Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume Share Forecast by Region (2018-2025)
Figure United States Acid Sphingomyelinase Deficiency Drug Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources